EHMTI-0090. Botox in the prevention of chronic migraine; comparing NICE criteria versus hull criteria for evaluating responder rate

por Zafar, H, Khalil, M, Ahmed, F
Publicado 2014

EHMTI-0133. Does medication overuse matter? Response to botulinum toxin type A in chronic migraine in patients with or without medication overuse

por Zafar, H, Khalil, M, Ahmed, F
Publicado 2014

EHMTI-0223. Botox in the prevention of chronic migraine; 18-months follow up outcome in 67 patients

por Khalil, M, Zafar, H, Ahmed, F
Publicado 2014

EHMTI-0381. Visual images can prove to be an important tool to aid in the diagnosis of cluster headaches

por Khan, I, Zafar, H, Ahmed, F
Publicado 2014

COVID-19 Trends and Forecast in the Eastern Mediterranean Region With a Particular Focus on Pakistan

por Dil, Saima, Dil, Nyla, Maken, Zafar H
Publicado 2020

EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK

por Khalil, M, Zafar, H, Quarshie, V, Ahmed, F
Publicado 2014

Toxoplasmosis – A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries

por Flegr, Jaroslav, Prandota, Joseph, Sovičková, Michaela, Israili, Zafar H.
Publicado 2014

Effect of quadriceps and hamstrings muscle cooling on standing balance in healthy young men

por Alghadir, A.H., Anwer, S., Zafar, H., Al-Eisa, E.S.
Publicado 2017

Facile Electrochemical Determination of Methotrexate (MTX) Using Glassy Carbon Electrode-Modified with Electronically Disordered NiO Nanostructures

por Khand, Aftab A., Lakho, Saeed A., Tahira, Aneela, Ubaidullah, Mohd, Alothman, Asma A., Aljadoa, Khoulwod, Nafady, Ayman, Ibupoto, Zafar H.
Publicado 2021